A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia

    January 1998 in “ Drug safety ”
    Peter Ekman
    Studysummary Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Maximum Efficacy of Finasteride Is Obtained Within 6 Months and Maintained Over 6 Years European Urology · 1998
    2. The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia The New England Journal of Medicine · 1996
    3. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1992

    Related research 2

    1. The Effects of Finasteride on Scalp Skin and Serum Androgen Levels in Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1999
    2. The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia The New England Journal of Medicine · 1996